Mintz Partner and International Chair of Life Sciences Cheryl Reicin and Member Dean Farmer, PhD will be speaking on two panels at the BayOConnect Forum for Biotech & Life Science (BayOConnect) in Munich on July 2. 

Cheryl will participate in a panel discussion entitled, “Risk and Reward – Comparative Strategies in Biotech Funding” and Dean will provide an introductory framework for a panel focused on “Translating Science – Keys to Commercializing Biotech Research.”

Cheryl is an internationally recognized advisor to life sciences companies and some of the industry’s largest investors. She assists clients in developing innovative strategies for domestic and international growth and advises on highly complex transactions around the globe. She represents biotechnology, medical device, and health technology companies at all stages of their development, from inventors and start-ups to major public corporations, as well as venture capitalists, investment banks, and academic medical centers.

Dean is a leading patent strategist in the life sciences sector who works with biotechnology and pharmaceutical companies at all stages of development. His clients range from start-ups, to mid-size pharmas with NCEs entering clinical trials, to large companies with vast patent portfolios.

BayOConnect “brings together visionary thinkers, innovative companies, and life science enthusiasts from the Bavarian biotech landscape and around the world the accelerate the progress of biotechnology in healthcare and medicine,” according to the BayOConnect website.